0001209191-21-060895.txt : 20211019
0001209191-21-060895.hdr.sgml : 20211019
20211019161515
ACCESSION NUMBER: 0001209191-21-060895
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211015
FILED AS OF DATE: 20211019
DATE AS OF CHANGE: 20211019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schlesinger Michael A.
CENTRAL INDEX KEY: 0001839441
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39956
FILM NUMBER: 211331095
MAIL ADDRESS:
STREET 1: C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS
STREET 2: 1001 ROUTE 202
CITY: RARITAN
STATE: NJ
ZIP: 08869
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ortho Clinical Diagnostics Holdings plc
CENTRAL INDEX KEY: 0001828443
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 981151819
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 1001 ROUTE 202
CITY: RARITAN
STATE: NJ
ZIP: 08869
BUSINESS PHONE: (908) 218-8000
MAIL ADDRESS:
STREET 1: 1001 ROUTE 202
CITY: RARITAN
STATE: NJ
ZIP: 08869
FORMER COMPANY:
FORMER CONFORMED NAME: Ortho-Clinical Diagnostics Bermuda Co. Ltd.
DATE OF NAME CHANGE: 20201015
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-15
0
0001828443
Ortho Clinical Diagnostics Holdings plc
OCDX
0001839441
Schlesinger Michael A.
C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS
1001 ROUTE 202
RARITAN
NJ
08869
0
1
0
0
EVP, GC and Secretary
Ordinary Shares, $0.00001 par value
2021-10-15
4
M
0
75464
6.28
A
163101
D
Ordinary Shares, $0.00001 par value
2021-10-15
4
S
0
75464
19.7314
D
87637
D
Stock Option
6.28
2021-10-15
4
M
0
75464
0.00
D
2024-10-22
Ordinary Shares, $0.00001 par value
75464
218043
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
Represents the weighted average sales price for the price increments ranging from $19.5900 to $19.9200.
The stock option is fully vested and exercisable.
/s/ Michael A. Schlesinger
2021-10-19